We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $46.3B
1-Year Est. Return 43.9%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+648.16%
AUM
$36.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.53B
Cap. Flow %
6.98%
Top 10 Hldgs %
34.28%
Holding
1,878
New
44
Increased
1,328
Reduced
301
Closed
46

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$448M
2
TSLA icon
Tesla
TSLA
+$327M
3
BAC icon
Bank of America
BAC
+$242M
4
NFLX icon
Netflix
NFLX
+$228M
5
IBM icon
IBM
IBM
+$178M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$305M
2
AMZN icon
Amazon
AMZN
+$251M
3
META icon
Meta Platforms (Facebook)
META
+$251M
4
ACN icon
Accenture
ACN
+$169M
5
APP icon
Applovin
APP
+$138M

Sector Composition

Rank Sector Weight
1 Technology 34.29%
2 Healthcare 13.65%
3 Financials 13.36%
4 Consumer Discretionary 10.64%
5 Communication Services 10.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAFT icon
1601
Safety Insurance
SAFT
$1.52B
$82K ﹤0.01%
1,000
+343
+52% +$28.4K
WT icon
1602
WisdomTree
WT
$3.26B
$82K ﹤0.01%
7,792
+2,540
+48% +$27.5K
HELE icon
1603
Helen of Troy
HELE
$671M
$81K ﹤0.01%
1,352
+571
+73% +$38K
IESC icon
1604
IES Holdings
IESC
$15.3B
$81K ﹤0.01%
401
+138
+52% +$33.2K
NWN icon
1605
Northwest Natural Holdings
NWN
$2.14B
$81K ﹤0.01%
2,054
+874
+74% +$35.6K
PGNY icon
1606
Progyny
PGNY
$2.37B
$81K ﹤0.01%
4,669
+2,140
+85% +$33.2K
PTGX icon
1607
Protagonist Therapeutics
PTGX
$9.4B
$81K ﹤0.01%
2,093
+737
+54% +$32.1K
AMPH icon
1608
Amphastar Pharmaceuticals
AMPH
$873M
$80K ﹤0.01%
2,159
+650
+43% +$29.7K
AORT icon
1609
Artivion
AORT
$1.29B
$80K ﹤0.01%
2,813
+1,254
+80% +$34.8K
KMT icon
1610
Kennametal
KMT
$2.58B
$80K ﹤0.01%
3,351
+1,122
+50% +$29.9K
LMND icon
1611
Lemonade
LMND
$4.01B
$80K ﹤0.01%
+2,177
New +$69.5K
MYGN icon
1612
Myriad Genetics
MYGN
$304M
$80K ﹤0.01%
5,845
+3,334
+133% +$61.5K
NVEE
1613
DELISTED
NV5 Global
NVEE
$80K ﹤0.01%
4,223
+1,531
+57% +$33.6K
TDOC icon
1614
Teladoc Health
TDOC
$1.21B
$80K ﹤0.01%
8,849
+3,714
+72% +$35.9K
ASTH icon
1615
Astrana Health
ASTH
$1.69B
$80K ﹤0.01%
2,530
+1,316
+108% +$62.5K
PFBC icon
1616
Preferred Bank
PFBC
$1.25B
$79K ﹤0.01%
914
+289
+46% +$25.5K
COUR icon
1617
Coursera
COUR
$1.59B
$78K ﹤0.01%
9,203
+4,376
+91% +$33.8K
SPT icon
1618
Sprout Social
SPT
$492M
$78K ﹤0.01%
2,525
+1,099
+77% +$33K
TNC icon
1619
Tennant Co
TNC
$1.31B
$78K ﹤0.01%
961
+394
+69% +$34.7K
TWO
1620
Two Harbors Investment
TWO
$1.26B
$78K ﹤0.01%
6,635
+3,077
+86% +$37.2K
XRX icon
1621
Xerox
XRX
$424M
$78K ﹤0.01%
9,223
+4,224
+84% +$39K
BCRX icon
1622
BioCryst Pharmaceuticals
BCRX
$2.36B
$77K ﹤0.01%
10,198
+4,537
+80% +$34.4K
EPC icon
1623
Edgewell Personal Care
EPC
$1.3B
$77K ﹤0.01%
2,279
+823
+57% +$29.1K
IMVT icon
1624
Immunovant
IMVT
$8.2B
$77K ﹤0.01%
3,099
+1,163
+60% +$33K
MCRI icon
1625
Monarch Casino & Resort
MCRI
$2.19B
$77K ﹤0.01%
980
+396
+68% +$31.9K

Similar funds

KBC Group's Q4 2024 Portfolio in Review

As of Q4 2024, KBC Group held 1,878 positions worth $36.3B, up 9.7% from $33.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

KBC Group deployed $2.53B of net new capital in Q4 2024, opening 44 new positions and adding to 1,328 existing holdings. Its largest new stake was Primo Brands: 1,611,484 shares worth $49.6M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Procter & Gamble, an estimated $305M trimmed.

  • KBC Group's largest Q4 2024 buy was Primo Brands: 1,611,484 shares worth $49.6M.
  • KBC Group added most to Apple in Q4 2024, an estimated $448M increase.
  • KBC Group's biggest Q4 2024 reduction was Procter & Gamble, cutting an estimated $305M.
  • KBC Group fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $4.35M.
  • KBC Group's ten largest holdings make up 34% of its $36.3B portfolio in Q4 2024.
  • KBC Group opened 44 new positions and closed 46 in Q4 2024.
  • KBC Group's portfolio value rose 9.7% quarter-over-quarter to $36.3B.

Based on KBC Group's 13F filing for Q4 2024, filed 22 Jan 2025.